Fulcrum Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell FULC and other ETFs, options, and stocks.About FULC
Fulcrum Therapeutics, Inc. is a clinical stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies. Its product candidate includes Losmapimod and FTX-HbF.
CEOAlexander C. Sapir
CEOAlexander C. Sapir
Employees45
Employees45
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2015
Founded2015
Employees45
Employees45
FULC Key Statistics
Market cap698.13M
Market cap698.13M
Price-Earnings ratio-10.96
Price-Earnings ratio-10.96
Dividend yield—
Dividend yield—
Average volume4.37M
Average volume4.37M
High today$13.26
High today$13.26
Low today$12.58
Low today$12.58
Open price$12.92
Open price$12.92
Volume2.09M
Volume2.09M
52 Week high$15.74
52 Week high$15.74
52 Week low$2.32
52 Week low$2.32
Stock Snapshot
As of today, Fulcrum Therapeutics(FULC) shares are valued at $12.67. The company's market cap stands at 698.13M, with a P/E ratio of -10.96.
On 2025-12-16, Fulcrum Therapeutics(FULC) stock traded between a low of $12.58 and a high of $13.26. Shares are currently priced at $12.67, which is +0.7% above the low and -4.4% below the high.
The Fulcrum Therapeutics(FULC)'s current trading volume is 2.09M, compared to an average daily volume of 4.37M.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
During the past year, Fulcrum Therapeutics(FULC) stock moved between $2.32 at its lowest and $15.74 at its peak.
Analyst ratings
78%
of 9 ratingsBuy
77.8%
Hold
11.1%
Sell
11.1%
People also own
Based on the portfolios of people who own FULC. This list is generated using Robinhood data, and it’s not a recommendation.